BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12945096)

  • 1. [Early and loud].
    Schellong S
    Vasa; 2003 May; 32(2):59-60. PubMed ID: 12945096
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
    Malik V; Kupfer Y; Tessler S
    N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14658127
    [No Abstract]   [Full Text] [Related]  

  • 3. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
    Brotman DJ
    N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14658124
    [No Abstract]   [Full Text] [Related]  

  • 4. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
    Huisman MV; van der Meer FJ; van Rooden CJ; Prins MH
    N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14645647
    [No Abstract]   [Full Text] [Related]  

  • 5. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
    Ridker PM; Goldhaber SZ; Glynn RJ
    N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14658125
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
    Tran HA
    N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14658126
    [No Abstract]   [Full Text] [Related]  

  • 7. Secondary prophylaxis with warfarin for venous thromboembolism.
    Büller HR; Prins MH
    N Engl J Med; 2003 Aug; 349(7):702-4. PubMed ID: 12917308
    [No Abstract]   [Full Text] [Related]  

  • 8. Venous thrombosis as a chronic disease.
    Schafer AI
    N Engl J Med; 1999 Mar; 340(12):955-6. PubMed ID: 10089190
    [No Abstract]   [Full Text] [Related]  

  • 9. [Advice for patients taking oral anticoagulants (coumadin or Previscan)].
    Rev Prat; 2007 Apr; 57(7):768. PubMed ID: 17626322
    [No Abstract]   [Full Text] [Related]  

  • 10. Is low-molecular-weight heparin safer than warfarin for secondary prevention of venous thromboembolism in cancer patients?
    Caine GJ; Lip GY
    Arch Intern Med; 2003 May; 163(10):1243-4; author reply 1244. PubMed ID: 12767973
    [No Abstract]   [Full Text] [Related]  

  • 11. International normalized ratio and anticoagulation.
    Theerman MR
    Arch Intern Med; 2003 May; 163(10):1242-3; author reply 1244. PubMed ID: 12767971
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    Ridker PM; Goldhaber SZ; Danielson E; Rosenberg Y; Eby CS; Deitcher SR; Cushman M; Moll S; Kessler CM; Elliott CG; Paulson R; Wong T; Bauer KA; Schwartz BA; Miletich JP; Bounameaux H; Glynn RJ;
    N Engl J Med; 2003 Apr; 348(15):1425-34. PubMed ID: 12601075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative management of oral anticoagulation.
    O'Donnell M; Kearon C
    Cardiol Clin; 2008 May; 26(2):299-309, viii. PubMed ID: 18407002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.
    Kearon C; Gent M; Hirsh J; Weitz J; Kovacs MJ; Anderson DR; Turpie AG; Green D; Ginsberg JS; Wells P; MacKinnon B; Julian JA
    N Engl J Med; 1999 Mar; 340(12):901-7. PubMed ID: 10089183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines on oral anticoagulation with warfarin - fourth edition.
    Keeling D; Baglin T; Tait C; Watson H; Perry D; Baglin C; Kitchen S; Makris M;
    Br J Haematol; 2011 Aug; 154(3):311-24. PubMed ID: 21671894
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-term prophylaxis after venous thromboembolism].
    Gøtze JP; Friis-Hansen LJ; Thorsen S; Rehfeld JF
    Ugeskr Laeger; 2003 Jul; 165(29):2896-7. PubMed ID: 12908362
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome.
    Crowther MA; Ginsberg JS; Julian J; Denburg J; Hirsh J; Douketis J; Laskin C; Fortin P; Anderson D; Kearon C; Clarke A; Geerts W; Forgie M; Green D; Costantini L; Yacura W; Wilson S; Gent M; Kovacs MJ
    N Engl J Med; 2003 Sep; 349(12):1133-8. PubMed ID: 13679527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin for venous thromboembolism - walking the dosing tightrope.
    Schafer AI
    N Engl J Med; 2003 Apr; 348(15):1478-80. PubMed ID: 12601074
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term standard-dose warfarin to prevent thrombosis.
    Depenbrock PJ
    Am Fam Physician; 2005 Jul; 72(1):36, 41. PubMed ID: 16035681
    [No Abstract]   [Full Text] [Related]  

  • 20. [Management of oral anticoagulation during invasive procedures].
    Watzke HH
    Wien Med Wochenschr; 2005 Jan; 155(1-2):22-5. PubMed ID: 15773740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.